Clinipace Inc. Selected to Manage Prometheus Laboratories Inc. Oncology Program
7/17/2012 9:56:45 AM
MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinipace Worldwide, a global digital research organization (dCRO), today announced Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, has awarded the company an Oncology Program. Immediate plans are commencing for two metastatic melanoma studies.